Predictive Biosciences’ $25M Series C round to pay for clinical trials
Predictive Biosciences plans to use its now-completed $25 million Series C round to begin commercializing its biomarker-based bladder cancer test. Predictive Biosciences completed a $25 million Series...
View ArticleMedicine in a microchip: Implant holds up to 400 doses, could replace needles
Earlier this summer, we saw the first “smart pill” from Proteus Digital Health receive U.S. Food and Drug Administration clearance, a huge step in connecting drug delivery with mobile technologies. So...
View ArticleMedicine in a microchip: Implant holds up to 400 doses, could replace needles
Earlier this summer, we saw the first “smart pill” from Proteus Digital Health receive U.S. […]
View Article
More Pages to Explore .....